Ideal Cures Revenue and Competitors

Mumbai, IND

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Ideal Cures's estimated annual revenue is currently $19.5M per year.(i)
  • Ideal Cures's estimated revenue per employee is $100,500

Employee Data

  • Ideal Cures has 194 Employees.(i)

Ideal Cures's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$56.6M56321%N/AN/A
#2
$15.6M15528%N/AN/A
#3
$17M169-11%N/AN/A
#4
$13.2M1318%N/AN/A
#5
$19.6M19510%N/AN/A
#6
$23.5M2347%N/AN/A
#7
$5.3M530%N/AN/A
#8
$13M129-25%N/AN/A
#9
$20.5M20411%N/AN/A
#10
$11.7M1166%N/AN/A
Add Company

What Is Ideal Cures?

Ideal Cures Pvt. Ltd. is the world's leading manufacturer and exporter of pharmaceutical excipients and ready-to-use coating systems for solid oral dosage forms. The product portfolio comprises INSTACOAT ready-to-use film coating systems, INSTANUTE coating technology for nutraceuticals and dietary supplements, ECOPOL range of Pharma Acrylic Polymer's, ECOCOOL brand of cooling compounds, ESPHERES range of sugar, MCC, silicon & calcium carbonate spheres. We have three manufacturing plants located in India at Vasai, Jammu and Khambat along with two modern R&D facilities at Mumbai and Vasai. Our state-of-the-art manufacturing facilities are strongly backed by our technical services, value added products and global regulatory support including maintenance of US Drug Master Files for almost all our products. Our highly qualified and experienced technical team provides technical support to the customers whenever required. We have a long term commitment to quality, research and development, sufficient capacity and adherence to current good manufacturing practices. By virtue of our vast experience with regards to pharmaceutical solid oral dosage forms, we possess in-house capabilities in the development and use of various excipients thereby creating a niche in Pharmaceutical, Herbal, Nutraceutical & Veterinary industries.

keywords:N/A

N/A

Total Funding

194

Number of Employees

$19.5M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ideal Cures News

2022-04-19 - Dr. Maro: Pet allergy solutions: Options other than steroids

The first step in determining the ideal therapy for a pet is to confirm ... responding to traditional allergy treatments and in some cases,...

2022-04-17 - Tablet Coatings Market Size, Outlook And Forecast | Colorcon ...

... Outlook And Forecast | Colorcon ( BPSI Holdings), Sensient, Evonik, BASF, Kerry, Ideal Cures, GEA Process Engineering, Contract Coating.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$26.7M194-28%N/A
#2
$21.9M1948%N/A
#3
$32.5M1941%N/A
#4
$24.3M1954%N/A
#5
$19.6M19510%N/A